[1]
2026. Safety Evaluation of EGFR-TKI Therapy in Patients with Non-Small Cell Lung Cancer: A Real-World Study Based on theFAERS Database. Clinical Medicine and Pharmacology. 3, 2 (Mar. 2026), 1–13. DOI:https://doi.org/10.70731/0yk94f55.